Treatment with Allogenic Mesenchymal Stromal Cells in a Murine Model of Systemic Lupus Erythematosus

OBJECTIVE: Pre-clinical and uncontrolled studies in patients with systemic lupus erythematosus (SLE) showed that mesenchymal stromal cells (MSCs) have a potential therapeutic role in refractory cases. The optimal therapeutic strategy in these patients remain to be elucidated. Our aim was to test the...

Descripción completa

Detalles Bibliográficos
Autores principales: Tani, Chiara, Vagnani, Sabrina, Carli, Linda, Querci, Francesca, Kühl, Anja A., Spieckermann, Simone, Cieluch, Constanze Pamela, Pacini, Simone, Fazzi, Rita, Mosca, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Stem Cell Research 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741197/
https://www.ncbi.nlm.nih.gov/pubmed/29186654
http://dx.doi.org/10.15283/ijsc17014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741197/
https://www.ncbi.nlm.nih.gov/pubmed/29186654
http://dx.doi.org/10.15283/ijsc17014

Ejemplares similares